Search

Author/Creator Impellizeri, J.

2. Overexpression of HER‐2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma ‐ A marker of malignancy and possible therapeutic target. (4th September 2017)

Authors:
Millanta, F.; Impellizeri, J.; McSherry, L.; Rocchigiani, G.; Aurisicchio, L.; Lubas, G.
Journal:
Veterinary and comparative oncology
Issue:
Volume 16:Number 2(2018:Jun.)
Page Start:
297
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model1. (10th April 2015)

Authors:
Kicenuik, K.; Northrup, N.; Dawson, A.; Locke, J.; Villamil, J. A.; Chretin, J.; Sfiligoi, G.; Clifford, C.; Rosenberg, M.; Hamilton, T.; Regan, R.; Parsons‐Doherty, M.; Mallett, C.; Philibert, J.; Impellizeri, J.; Hofmeister, E.
Journal:
Veterinary and comparative oncology
Issue:
Volume 15:Number 1(2017:Mar.)
Page Start:
163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗